Fournier's gangrene in a man on empagliflozin for treatment of Type 2 diabetes

Diabetic Medicine

Volumn 34, Issue 11, 2017, Pages 1646-1648

  Kumar, S ^a   Costello, A J ^a   Colman, P G ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; C REACTIVE PROTEIN; EMPAGLIFLOZIN; GENTAMICIN; GLUCOSE; HEMOGLOBIN A1C; INSULIN; MEROPENEM; METFORMIN; ORAL ANTIDIABETIC AGENT; VANCOMYCIN; BENZHYDRYL DERIVATIVE; GLUCOSIDE;

ADULT; ANTIFUNGAL THERAPY; ARTICLE; BODY MASS; CASE REPORT; CLINICAL ARTICLE; COLOSTOMY; COMPUTER ASSISTED TOMOGRAPHY; DEBRIDEMENT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FOURNIER GANGRENE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPEREMIA; HYPERGLYCEMIA; LENGTH OF STAY; LEUKOCYTE COUNT; LYMPHADENOPATHY; MALE; MEDICAL HISTORY; MICROBIAL GROWTH; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT COMPLIANCE; PATIENT COUNSELING; SCROTAL PAIN; SCROTAL SWELLING; SMOKING; SMOKING CESSATION; SPLIT THICKNESS SKIN GRAFT; STREPTOCOCCUS ANGINOSUS; THRUSH; TREATMENT DURATION; CHEMICALLY INDUCED; COMBINATION DRUG THERAPY; DIAGNOSTIC IMAGING; MALE GENITAL SYSTEM DISEASE; PATHOLOGY; SCROTUM;

ADULT; BENZHYDRYL COMPOUNDS; DIABETES MELLITUS, TYPE 2; DRUG SUBSTITUTION; DRUG THERAPY, COMBINATION; FOURNIER GANGRENE; GENITAL DISEASES, MALE; GLUCOSIDES; HUMANS; INSULIN; MALE; METFORMIN; SCROTUM;

EID: 85031497678     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.13508     Document Type: Article

References (7)

1. Cefalu WT, Riddle MC. SLGT2 inhibitors: the latest ‘new kids on the block’. Diabetes Care 2015; 38: 352–354.
2. Kim SY, Dupree JM, Le BV, Kim DY, Zhao LC, Kundu SD. A contemporary analysis of Fournier gangrene using the National Surgical Quality Improvement Program. Urology 2015; 85: 1052–1056.
3. Faria SN, Helman A. Deep tissue infection of the perineum; case report and literature review of Fournier gangrene. Can Fam Physician 2016; 62: 405–407.
4. Wong CH, Chang HC, Pasupathy S, Khin LW, Tan JL, Low CO. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am 2003; 85-A: 1454–1460.
5. Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis 2014; 59: 147–159.
6. Wysoki MG, Santora TA, Shah RM, Friedman AC. Necrotizing fasciitis: CT characteristics. Radiology 1997; 203: 859–863.
7. Chi W, Lim-Tio S. Fournier's Syndrome: a life-threatening complication of SGLT2 inhibition in poorly controlled diabetes mellitus[abstract]. Australian Diabetes Society (ADS) and Australian Diabetes Educators Association (ADEA) 2016 Annual Scientific Meeting; 24–26th August 2016; Gold Coast Australia. Abstract number 265.